Lunit Archives - HIT Leaders and News https://us.hitleaders.news/tag/lunit/ Healthcare Innovations and technology news and views Sun, 03 Aug 2025 01:02:49 +0000 en-US hourly 1 https://wordpress.org/?v=7.0.1 AI Elevates Tomosynthesis Cancer Detection https://us.hitleaders.news/imaging/49377/ai-elevates-tomosynthesis-cancer-detection/?utm_source=rss&utm_medium=rss&utm_campaign=ai-elevates-tomosynthesis-cancer-detection Tue, 05 Aug 2025 11:59:15 +0000 https://us.hitleaders.news/?p=49377 Digital breast tomosynthesis entered U.S. screening programs with the promise of sharper lesion visualization and fewer unnecessary recalls. Despite those gains, interval breast cancers, tumors discovered symptomatically after a negative exam and before the next scheduled visit, continue to undermine clinical and financial goals.

The post AI Elevates Tomosynthesis Cancer Detection appeared first on HIT Leaders and News.

]]> Lunit to Present Seven AI-Powered Radiology Studies at RSNA 2023 https://us.hitleaders.news/imaging/41545/lunit-to-present-seven-ai-powered-radiology-studies-at-rsna-2023/?utm_source=rss&utm_medium=rss&utm_campaign=lunit-to-present-seven-ai-powered-radiology-studies-at-rsna-2023 Wed, 15 Nov 2023 13:30:15 +0000 https://us.hitleaders.news/?p=41545 Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, is set to unveil seven significant abstracts at the Radiological Society of North America (RSNA) 2023 Annual Meeting, taking place from November 26 to November 30 in Chicago.

The post Lunit to Present Seven AI-Powered Radiology Studies at RSNA 2023 appeared first on HIT Leaders and News.

]]> Lunit Enters into Research Collaboration to Explore the Use of AI to Improve the Effectiveness of Immunotherapy https://us.hitleaders.news/media-resources/press-releases-and-announcements/41493/lunit-enters-into-research-collaboration-to-explore-the-use-of-ai-to-improve-the-effectiveness-of-immunotherapy/?utm_source=rss&utm_medium=rss&utm_campaign=lunit-enters-into-research-collaboration-to-explore-the-use-of-ai-to-improve-the-effectiveness-of-immunotherapy Thu, 02 Nov 2023 11:05:54 +0000 https://us.hitleaders.news/?p=41493 Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, announced a research collaboration with The University of Texas MD Anderson Cancer Center to analyze the use of Merck's (known as MSD outside the US and Canada) Keytruda (pembrolizumab), a type of immunotherapy drug used in cancer treatment, in multiple cancer types.

The post Lunit Enters into Research Collaboration to Explore the Use of AI to Improve the Effectiveness of Immunotherapy appeared first on HIT Leaders and News.

]]> Lunit’s AI-Powered Lung Cancer Screening Solution Significantly Affects Radiologists’ Diagnostic Determination https://us.hitleaders.news/imaging/40732/lunits-ai-powered-lung-cancer-screening-solution-significantly-affects-radiologists-diagnostic-determination/?utm_source=rss&utm_medium=rss&utm_campaign=lunits-ai-powered-lung-cancer-screening-solution-significantly-affects-radiologists-diagnostic-determination Mon, 10 Jul 2023 20:55:48 +0000 https://us.hitleaders.news/?p=40732 Lunit, a provider of AI-powered cancer diagnostics solutions, announced the publication of a study exploring the impact of medical AI solutions' accuracy on radiologists' diagnostic determination. The study, conducted by Seoul National University Hospital from December 2015 to February 2021, was recently published in 'Radiology,' a renowned peer-reviewed journal in medical imaging.

The post Lunit’s AI-Powered Lung Cancer Screening Solution Significantly Affects Radiologists’ Diagnostic Determination appeared first on HIT Leaders and News.

]]> Lunit Unveils Real-World Data Backing Clinical Efficacy of AI for the First Time in Breast Cancer Research https://us.hitleaders.news/imaging/38680/lunit-unveils-real-world-data-backing-clinical-efficacy-of-ai-for-the-first-time-in-breast-cancer-research/?utm_source=rss&utm_medium=rss&utm_campaign=lunit-unveils-real-world-data-backing-clinical-efficacy-of-ai-for-the-first-time-in-breast-cancer-research Tue, 29 Nov 2022 07:50:34 +0000 https://us.hitleaders.news/?p=38680 Lunit, a provider of AI-powered cancer solutions, announced that it unveiled real-world data (RWD) validating the clinical efficacy of AI in actual medical settings for the first time in the field of breast cancer research at this year's RSNA meeting. The company will be presenting a total of 12 abstracts—8 oral presentations and 4 poster presentations—at the 108th RSNA Annual Meeting to be held from Nov. 27 – Dec. 1.

The post Lunit Unveils Real-World Data Backing Clinical Efficacy of AI for the First Time in Breast Cancer Research appeared first on HIT Leaders and News.

]]>